Effective Duty Rate
0% MFN base; Section 301 applies to some API categories at 25%
Estimate — verify by HTS code
Compliance Risk
High
Relative to other import corridors
Regulatory Agencies
FDA, DEA, EPA
Primary oversight bodies
OVERVIEW
Importing Pharmaceutical Products & Active Ingredients from China
Pharmaceuticals imported from China to the United States is subject to CBP entry requirements, applicable HTS-based duty rates, and agency compliance clearances. This guide covers the complete import process for 2026.
⚠ Key Trade Intelligence — China Origin
China is the dominant global supplier of active pharmaceutical ingredients (APIs) and intermediates. Most finished pharma products enter at 0% MFN under WTO Pharma Agreement, but some API precursors face 25% Section 301 (List 3). FDA has increased scrutiny of Chinese pharma facilities following quality incidents.
APPLICABLE HTS CODES
HTS Codes for Pharmaceuticals Imports
The following Harmonized Tariff Schedule (HTS) codes typically apply to pharmaceuticals imports. Exact classification depends on the specific product — misclassification is one of the most common CBP compliance errors.
| HTS Code |
Product Description |
MFN Base Duty Rate |
| 3003 |
Medicaments (not in measured doses) |
0% MFN |
| 3004 |
Medicaments in Measured Doses (retail packaged) |
0% MFN |
| 3002 |
Vaccines, Blood Products & Antisera |
0% MFN |
| 2941 |
Antibiotics (bulk active pharmaceutical ingredients) |
0% MFN (WTO Pharma Agreement) |
| 2942 |
Other Organic Compounds (pharma intermediates) |
0%–6.5% MFN |
MFN rates reflect base tariff. Additional duties (Section 301, Section 232, AD/CVD) may apply on top of MFN rates. Use the AI classifier to get the exact 10-digit HTS code and all applicable rates for your specific product.
DUTY STACK — CHINA ORIGIN
Total Tariff Cost for China-Origin Pharmaceuticals
| Duty Layer |
Rate / Status |
Applies To |
| MFN Base Rate |
Varies by HTS code |
All China-origin goods (baseline) |
| Section 301 Additional Duty |
7.5%–25% additional |
Most product categories from China |
| Section 232 (Steel/Aluminum) |
25% steel / 10% aluminum |
Steel and aluminum imports from China |
COMPLIANCE — FDA / DEA / EPA
US Compliance Requirements for Pharmaceuticals Imports
Regardless of origin country, pharmaceuticals imports must satisfy the following US regulatory requirements before or at the time of CBP entry filing:
- FDA prior notice of imported food/drug shipments — FDA Form 2877 (Entry Notice) required; finished drugs must comply with NDA/ANDA or be the subject of an approved IND
- cGMP (Current Good Manufacturing Practice) compliance — FDA may inspect foreign manufacturing facilities; Drug Master File (DMF) required for active ingredients
- DEA registration and import permit required for Schedule II–V controlled substances; Form DEA-236 Import Declaration
- FDA Establishment Registration and Drug Listing — foreign manufacturers must register with FDA and list all drugs they manufacture for US distribution
Compliance Check Tool
Run an automated compliance check for your pharmaceuticals import — identifies all applicable agency requirements, flagging issues before your shipment departs China.
Run Compliance Check →
REQUIRED DOCUMENTS
Documentation Checklist for Pharmaceuticals from China
Prepare all documents before the shipment departs China. Missing or incorrect documents are the #1 cause of CBP holds and customs delays.
1
Commercial Invoice with drug name (INN/USAN), strength, dosage form, and NDA/ANDA number
2
Packing List with batch/lot numbers
3
Bill of Lading or Airway Bill (temperature-controlled documentation for cold-chain products)
4
FDA Drug Import Entry form and Prior Notice confirmation
5
Certificate of Analysis (CoA) for each batch/lot
6
cGMP compliance certificate from manufacturing facility
ESTIMATED TIMELINE
Import Timeline — Pharmaceuticals from China
3–7 days (air freight for temperature-sensitive products); 15–30 days (ocean for bulk APIs)
Supplier Preparation
Allow 1–2 weeks for production documentation, certificates, and packing lists
Transit Time
18–35 days ocean from Asia/origin
CBP Clearance
1–3 days standard; 5–15 days if examination or AD/CVD review required
FREQUENTLY ASKED QUESTIONS
FAQs — Importing Pharmaceuticals from China
What is the effective US tariff rate for importing pharmaceuticals from China?
The effective US tariff rate for pharmaceuticals from China is: 0% MFN base; Section 301 applies to some API categories at 25%. China is the dominant global supplier of active pharmaceutical ingredients (APIs) and intermediates. Most finished pharma products enter at 0% MFN under WTO Pharma Agreement, but some API precursors face 25% Section 301 (List 3). FDA has increased scrutiny of Chinese pharma facilities following quality incidents.
What compliance agencies regulate pharmaceuticals imports from China?
Pharmaceuticals imports require compliance with: FDA, DEA, EPA. Specific requirements include: FDA prior notice of imported food/drug shipments — FDA Form 2877 (Entry Notice) required; finished drugs must comply with NDA/ANDA or be the subject of an approved IND and cGMP (Current Good Manufacturing Practice) compliance — FDA may inspect foreign manufacturing facilities; Drug Master File (DMF) required for active ingredients.
What documents are required to import pharmaceuticals from China?
Required documents include: Commercial Invoice with drug name (INN/USAN), strength, dosage form, and NDA/ANDA number; Packing List with batch/lot numbers; Bill of Lading or Airway Bill (temperature-controlled documentation for cold-chain products); FDA Drug Import Entry form and Prior Notice confirmation. Additional: Certificate of Analysis (CoA) for each batch/lot; cGMP compliance certificate from manufacturing facility. Ensure all documents are prepared before the shipment departs China.
How long does customs clearance take for pharmaceuticals from China?
Typical timeline: 3–7 days (air freight for temperature-sensitive products); 15–30 days (ocean for bulk APIs). CBP clearance typically takes 1–3 business days for compliant entries. Complex entries (AD/CVD, formal entry review, or examination) may require 5–15 additional business days.
Are there Section 301 or Section 232 tariffs on pharmaceuticals from China?
Yes. China-origin pharmaceuticals is subject to Section 301 additional tariffs (7.5%–25% depending on HTS code and List). Section 232 duties also apply: 25% on steel products, 10% on aluminum. Total effective duty is substantially higher than the base MFN rate.
Ready to Calculate Your Exact Import Costs?
Get precise duty calculations, landed cost estimates, and compliance flags for your pharmaceuticals shipment from China.
RELATED IMPORT GUIDES
Also Importing Pharmaceuticals From Other Countries?
Other Products from China?
Import duty rates are sourced from the USITC Harmonized Tariff Schedule and USTR Section 301 lists. Rates reflect current published schedules as of 2026-04-06 and are subject to change. This page is for informational purposes only and does not constitute legal or customs brokerage advice. Verify rates with a licensed customs broker before importing.